Published in

Elsevier, Radiotherapy & Oncology, (154), p. 327-353, 2021

DOI: 10.1016/j.radonc.2020.11.018

Springer, Virchows Archiv, 2(478), p. 153-190, 2021

DOI: 10.1007/s00428-020-03007-z

BMJ Publishing Group, International Journal of Gynecological Cancer, 1(31), p. 12-39, 2020

DOI: 10.1136/ijgc-2020-002230

Links

Tools

Export citation

Search in Google Scholar

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Journal article published in 2020 by Ignace Vergote, Mansoor Raza Mirza, Simone Marnitz, Jonathan A. Ledermann ORCID, Anna Fagotti, Christina Fotopoulou ORCID, Antonio Gonzalez Martin, Antonio Gonzalez Martin, Xavier Matias-Guiu, Sigurd F. Lax, Domenica Lorusso, Christian Marth, Philippe Morice, Remi A. Nout, Carien L. Creutzberg and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.